Cardiac Expertise in the Heart of Tampa Bay
Personalized Heart Care
Your Heart Is Telling Us Something


Florida Hospital Pepin Heart Institute

The mission of the Dr. Kiran C. Patel Research Institute is to advance patient care through leading-edge, patient-focused clinical research. Patients who enroll and qualify for our clinical studies gain access to groundbreaking treatments not yet available at other hospitals. Furthermore, our clinical studies only include treatments that meet or exceed today’s standard of care for the treatment of disease.

Our clinical investigators are active members of the medical or nursing staffs in our hospital who have proven their devotion to patient care time and again. If you have general questions or would like to know if you qualify for any of our active clinical studies, please e-mail

If you have questions on a specific clinical trial from the list of active studies below, please e-mail the lead investigator listed for that particular research study. To learn more about the Dr. Kiran C. Patel Research Institute or see more details on our active research studies, please visit our hospital website.

ABLATE: Atrial Fibrillation (AF)

ABLATE AF is a clinical trial for treating patients with mild forms of atrial fibrillation who require cardiac ablation.
Lead Coordinator: Cynthia Paysor

ABSORB RCT: Ischemic Heart Disease

ABSORB III is a clinical study to evaluate the Absorb bioresorbable scaffold in the treatment of ischemic heart disease caused by coronary lesions.
Lead Coordinator: Beth Posey

ATHENA: Treatment of Chronic Myocardial Ischemia

ATHENA is a study to assess the use of stem cells delivered to the heart in the treatment of chronic ischemic heart disease in patients who are not eligible for percutaneous or surgical revascularization.
Lead Coordinator: Brian Nordgen

ATTRACT: Acute Venous Thrombosis

ATTRACT is a study to determine if initial treatment with catheter-directed thrombolysis in patients with symptomatic deep vein thrombosis (DVT) can reduce the occurrence of post-thrombotic syndrome (PTS).
Lead Coordinator: Juliet Bala

AWARE AKI M13-796: Acute Kidney Injury Prevention

AWARE is a clinical trial to evaluate dosing regimens of a new medication for the prevention of acute kidney injury in subjects undergoing high risk cardiac surgery.
Lead Coordinator: Yvonne Gopsill

CANTOS: Cardiovascular Risk Reduction

CANTOS is a trial aimed at the prevention of recurrent cardiovascular events in stable post-heart attack patients with elevated high-sensitivity C-Reactive Protein levels.
Lead Coordinator: Cynthia Paysor

COLOR: Cholesterol in Coronary Arteries

COLOR is an observational study of patients receiving InfraReDx LipiScan for the detection of lipid core containing plaques (LCP), which are rich in cholesterol.
Lead Coordinator: Brian Nordgen

EUCLID: Peripheral Artery Disease

EUCLID is a study to compare treatments on the risk of cardiac events in patients with established Peripheral Artery Disease (PAD).
Lead Coordinator: Juliet Bala

EVITA: Smoking Cessation and Post-Acute Coronary Syndrome

EVITA is a trial to evaluate the effectiveness of a smoking cessation treatment on patients who have suffered a heart attack.
Lead Coordinator: Michele Fewster

MASTER II: Acute ST Elevation Myocardial Infarction

MASTER II evaluates the safety and efficacy of the MGuard™ Prime stent in the treatment of coronary arteries in patients undergoing a stenting procedure due to having a heart attack.
Lead Coordinator: Shannon Harrison

ODYSSEY: Acute Coronary Syndrome

ODYSSEY is a study to evaluate a new medication to lower cholesterol on the prevention of cardiovascular events in patients who have experienced an acute coronary syndrome (ACS).
Lead Coordinator: Cynthia Paysor

OPEN: Peripheral Arterial Disease

OPEN is a study to evaluate the self-expanding FlexStent® which is designed to cope with the extreme demands of the superficial femoral artery (SFA)/proximal popliteal artery in patients with peripheral arterial disease.
Lead Coordinator: Diane Bashton

PARACHUTE IV:  Ischemic Heart Disease

PARACHUTE IV is a pivotal trial of the CardioKinetix Parachute Implant and its effectiveness on the treatment of ischemic heart failure.
Lead Coordinator: Cynthia Paysor

REGULATE: Coronary Arterial Disease

REGULATE is designed to determine the efficacy of medicationsin preventing complications in patients undergoing Percutaneous coronary intervention (PCI) as a treatment for coronary arterial disease.
Lead Coordinator: Shannon Harrison

SAPPHIRE: Stenting and Angioplasty

SAPPHIRE is a study to evaluate the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease in the high-risk population.
Lead Coordinator: Betsy Szymanski

SILVER AMI: Heart Attack in the Elderly

SILVER AMI is a research study of older persons who are admitted to the hospital with a heart attack.
Lead Coordinator: Michele Fewster


ZILVER is a is intended to evaluate the Zilver® Vena stent in the treatment of symptomatic iliofemoral venous outflow obstruction.
Lead Coordinator: Juliet Bala

← Back to main page